Jazz Pharmaceuticals plc Stock
Jazz Pharmaceuticals plc Stock
Jazz Pharmaceuticals plc gained 0.420% compared to yesterday.
The stock is an absolute favorite of our community with 38 Buy predictions and no Sell predictions.
As a result the target price of 173 € shows a slightly positive potential of 18.45% compared to the current price of 146.05 € for Jazz Pharmaceuticals plc.
Pros and Cons of Jazz Pharmaceuticals plc in the next few years
Pros
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Jazz Pharmaceuticals plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | 0.420% | 4.284% | 1.565% | 12.260% | 1.143% | 5.833% | 9.812% |
| Opko Health Inc. | 4.160% | 0.738% | -3.845% | -34.407% | -7.320% | -6.910% | -75.700% |
| Amicus Therapeutics Inc. | 0.000% | 0.833% | 0.833% | 33.702% | 0.833% | -1.434% | 24.742% |
| Viatris Inc. | -0.150% | 1.581% | 24.838% | 28.097% | 28.097% | 22.682% | -10.629% |
Comments
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its "buy" rating reaffirmed by analysts at TD Cowen.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target raised by analysts at Truist Financial Corporation from $220.00 to $230.00. They now have a "buy" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target raised by analysts at Needham & Company LLC from $210.00 to $235.00. They now have a "buy" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat